Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TAFINLAR for Malignant melanoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 23 adverse event reports in the FDA FAERS database where TAFINLAR was used for Malignant melanoma.

Most Reported Side Effects for TAFINLAR

Side Effect Reports % Deaths Hosp.
Pyrexia 29 24.0% 1 11
Death 14 11.6% 14 4
Rash 11 9.1% 0 2
Nausea 9 7.4% 0 4
Vomiting 9 7.4% 0 5
Chills 8 6.6% 1 2
Diarrhoea 7 5.8% 0 2
Disease progression 7 5.8% 4 0
Headache 6 5.0% 0 1
Arthralgia 5 4.1% 0 0
Decreased appetite 5 4.1% 1 1
Dehydration 5 4.1% 0 4
Myalgia 5 4.1% 0 2
Pain in extremity 5 4.1% 0 2

Other Indications for TAFINLAR

Metastatic malignant melanoma (65) Product used for unknown indication (15)

Other Drugs Used for Malignant melanoma

NIVOLUMAB (10,599) IPILIMUMAB (8,903) DABRAFENIB (5,277) TRAMETINIB DIMETHYL SULFOXIDE (3,841) PEMBROLIZUMAB (3,261) BINIMETINIB (2,613) ENCORAFENIB (2,591) VEMURAFENIB (2,548) TRAMETINIB (1,448) COBIMETINIB (1,324)

Related Pages

TAFINLAR Full Profile All Malignant melanoma Drugs TAFINLAR Demographics TAFINLAR Timeline